Icahn Mount Sinai ⁩ to Begin the Transfer of #COVID19 Antibodies into Critically Ill Patients

⁦@IcahnMountSinai⁩ to Begin the Transfer of #COVID19 Antibodies into Critically Ill Patients https://t.co/SOiU9K1d29

— Toni Choueiri, MD (@DrChoueiri) March 25, 2020